Clinical trial Recruiting at 6 sites Observational Ages 18 to 65

Fatigue Investigation Using Digital Outcomes

Official title: Fatigue Investigation Using Digital Outcomes (FIDO) - An Exploratory Project

Run by University of Zurich · NCT07783074 · Data updated 2026-11-12

This study tests whether digital monitoring with a smartphone app and wearables can track fatigue in people with MS or long COVID, compared with healthy volunteers.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment122 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations6 sites (Basel, Basel and 5 other locations)
StatusRecruiting
StartedMay 26, 2026
Main results expectedMay 1, 2028
Study endsMay 1, 2028
Registry record updatedAugust 24, 2026
Trial IDNCT07783074 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with MS or long COVID, plus healthy volunteers, who own a smartphone and can provide informed consent, and fluent in German or English.

Probably not a fit

Individuals unable to wear devices or comply with the app-based tasks, or with conditions that affect fatigue too variably, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational study collects continuous data from wearables and a smartphone app to characterize daily fatigue patterns in people with multiple sclerosis or long COVID, plus healthy controls. Participants wear devices and complete at-home cognitive and motor tests over about eight weeks, alongside periodic clinic visits. The goal is to see if digital measures correlate with standard fatigue assessments and to explore additional factors like sleep and autonomic function. Primary focus is feasibility of sustained wearable use and data completeness; secondary aims examine relationships between digital metrics and clinical or self-reported fatigue, with exploratory analyses including machine learning models for fatigue estimation.

Why it matters

Potential benefit: If successful, this approach could enable objective, real-time fatigue monitoring and improve understanding of fatigue fluctuations in these conditions.

How similar studies have gone: Previous work suggests digital biomarkers can reflect fatigue-related changes in neuroimmune and neuromuscular conditions, though this study is exploratory and builds on growing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria Multiple Sclerosis or Long COVID

* Confirmed diagnosis of MS (by neurologist) or Long COVID (by medical doctor).
* Smartphone ownership.
* Provide written informed consent.
* Fluent in German or English.

Inclusion Criteria Healthy:

* Smartphone ownership.
* Provide written informed consent.
* Fluent in German or English.

Exclusion Criteria:

* Concomitant medication affecting fatigue or ANS such as antidepressants prescribed or adjusted 1 month before the initial visit.
* Unable to provide informed consent.
* Unwilling or unable to comply with the study protocol.
* Pregnancy or lactation.
* For controls: Diagnosis of any chronic disorders or diseases that may affect fatigue or ANS.
* For MS: Additional comorbidities that may affect fatigue or ANS such as autoimmune disease and cardiovascular disease.
* For long COVID: Additional comorbidities diagnosed prior to the first acute COVID-19 infection that may affect fatigue or ANS such as autoimmune disease and cardiovascular disease.

Where it's running

  • Neurozentrum Basel Messeturm
    Basel, Basel, Switzerland
    Recruiting
  • Bellevue Medical Group - Neurozentrum Sternen / Neurozentrum Bellevue
    Zurich, Canton of Zurich, Switzerland
    Recruiting
  • University of Zurich
    Zurich, Canton of Zurich, Switzerland
    Recruiting
  • NeuroPraxis Zürich GmbH
    Zurich, Canton of Zurich, Switzerland
    Recruiting
  • Bellevue Medical Group - Neurozentrum Seefeld
    Zurich, Canton of Zurich, Switzerland
    Recruiting
  • Klinik Lengg AG
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.